These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters. Boncyk CS; Farrin E; Stollings JL; Rumbaugh K; Wilson JE; Marshall M; Feng X; Shotwell MS; Pandharipande PP; Hughes CG Anesth Analg; 2021 Sep; 133(3):713-722. PubMed ID: 33433117 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review. Grover S; Mattoo SK; Gupta N Pharmacopsychiatry; 2011 Mar; 44(2):43-54. PubMed ID: 21394715 [TBL] [Abstract][Full Text] [Related]
5. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Kales HC; Valenstein M; Kim HM; McCarthy JF; Ganoczy D; Cunningham F; Blow FC Am J Psychiatry; 2007 Oct; 164(10):1568-76; quiz 1623. PubMed ID: 17898349 [TBL] [Abstract][Full Text] [Related]
6. Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients. Helou R; Rhalimi M J Popul Ther Clin Pharmacol; 2010; 17(3):e379-89. PubMed ID: 21041864 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of high-risk medications in patients enrolled in the Hospital Elder Life Program. Macias Tejada JA; Klumph M; Heslin K; Khan A; Malone ML J Am Geriatr Soc; 2021 Jul; 69(7):1941-1947. PubMed ID: 33769554 [TBL] [Abstract][Full Text] [Related]
8. The impact of memantine and cholinesterase inhibitor initiation for Alzheimer disease on the use of antipsychotic agents: analysis using the Régie de l'Assurance Maladie du Québec database. Lachaine J; Beauchemin C; Crochard A; Bineau S Can J Psychiatry; 2013 Apr; 58(4):195-200. PubMed ID: 23547642 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study. Stephenson A; Seitz DP; Fischer HD; Gruneir A; Bell CM; Gershon AS; Fu L; Anderson GM; Austin PC; Rochon PA; Gill SS Drugs Aging; 2012 Mar; 29(3):213-223. PubMed ID: 22332932 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic Treatment of Intensive Care Unit Delirium and the Impact on Duration of Delirium, Length of Intensive Care Unit Stay, Length of Hospitalization, and 28-Day Mortality. Daniels LM; Nelson SB; Frank RD; Park JG Mayo Clin Proc; 2018 Dec; 93(12):1739-1748. PubMed ID: 30292426 [TBL] [Abstract][Full Text] [Related]
11. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy. Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582 [TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibitors for the treatment of delirium in non-ICU settings. Yu A; Wu S; Zhang Z; Dening T; Zhao S; Pinner G; Xia J; Yang D Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012494. PubMed ID: 29952000 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterase Inhibitor Use in Patients With Dementia Admitted to a Palliative Care Unit. Perri GA; Wilson J; Gardner S; Berall A; Kirstein A; Khosravani H Am J Hosp Palliat Care; 2021 Nov; 38(11):1356-1360. PubMed ID: 33401952 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic prescribing in people admitted to hospital with dementia or delirium. Tumusiime WA; Hardman CJ; Breen JL Australas J Ageing; 2022 Jun; 41(2):258-264. PubMed ID: 34792258 [TBL] [Abstract][Full Text] [Related]
15. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine. Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103 [TBL] [Abstract][Full Text] [Related]
16. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey. Seitz DP; Gruneir A; Conn DK; Rochon PA J Am Geriatr Soc; 2009 Dec; 57(12):2269-74. PubMed ID: 19874411 [TBL] [Abstract][Full Text] [Related]
17. Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study. Scharre DW; Vekeman F; Lefebvre P; Mody-Patel N; Kahler KH; Duh MS Drugs Aging; 2010 Nov; 27(11):903-13. PubMed ID: 20964464 [TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitor and memantine use in newly admitted nursing home residents with dementia. Parsons C; Briesacher BA; Givens JL; Chen Y; Tjia J J Am Geriatr Soc; 2011 Jul; 59(7):1253-9. PubMed ID: 21668913 [TBL] [Abstract][Full Text] [Related]
19. Effect of discontinuing cholinesterase inhibitor therapy on behavioral and mood symptoms in nursing home patients with dementia. Daiello LA; Ott BR; Lapane KL; Reinert SE; Machan JT; Dore DD Am J Geriatr Pharmacother; 2009 Apr; 7(2):74-83. PubMed ID: 19447360 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]